Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
about
Treatment approaches and adherence to urate-lowering therapy for patients with gout.Effects of renal function on pharmacokinetics and pharmacodynamics of lesinurad in adult volunteers.Current and future therapies for gout.Treatment Options for Gout.The safety of treatment options available for gout.Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study).Clinical Pharmacokinetics and Pharmacodynamics of Febuxostat.Gout: An old disease in new perspective - A review.Lesinurad: what the nephrologist should know.Gout: will the "King of Diseases" be the first rheumatic disease to be cured?Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.Emerging uricosurics for gout.The effect of kidney function on the urate lowering effect and safety of increasing allopurinol above doses based on creatinine clearance: a post hoc analysis of a randomized controlled trial.Guideline development for the management of gout: role of combination therapy with a focus on lesinurad.Lesinurad for the treatment of hyperuricaemia in people with gout.Recent pharmacological advances in the management of gout.Impact of non-adherence on the safety and efficacy of uric acid-lowering therapies in the treatment of gout.Novel uricosurics.Individualized treatment strategies for hyperuricemia informed by a semi-mechanistic exposure-response model of uric acid dynamics.Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and Commonly Used Drugs for Gout Treatment.Evaluation of Pharmacokinetic Interactions Between Lesinurad, a New Selective Urate Reabsorption Inhibitor, and CYP Enzyme Substrates Sildenafil, Amlodipine, Tolbutamide, and Repaglinide.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with allopurinol in adults with gout: a phase IIa, open-label study.Physiology of Hyperuricemia and Urate-Lowering Treatments.Pharmacodynamic and pharmacokinetic effects and safety of verinurad in combination with febuxostat in adults with gout: a phase IIa, open-label study.Pharmacokinetics, pharmacodynamics, and tolerability of verinurad, a selective uric acid reabsorption inhibitor, in healthy Japanese and non-Asian male subjects.
P2860
Q33597442-0D5B4856-3343-4590-9B3C-CAA21B7202CBQ37397859-C75F9CCC-39A3-4433-9914-54C38B29ABA0Q38660829-62A8C280-D5CE-4704-AAEB-EA5E8AE32F29Q38691902-580E10B4-E275-4F35-84B3-BC8277FD2CC2Q39092018-B136D06A-F429-4BE9-B020-4D5C5676FF19Q39207518-612006B0-84F1-4EB5-BDC6-23E45A18C394Q39278948-C1F5DC3D-199D-4DBA-9B15-0614B4A61355Q40106739-B1D0FFB0-0C72-4938-903F-6C94345839FAQ42091820-2BED3043-EAB9-42B6-8D47-65D602BB578EQ42370099-A03246E6-FAB2-44C8-9721-9EF66B867EF2Q42696818-96F1D5F1-6D30-434B-BC9F-716ED6815D63Q46204113-325330C7-9265-4765-AD98-DEEFF7F2FE3FQ47099047-F270FB2D-0780-461B-9271-003A77C70280Q47104482-C6FBBE3B-12ED-4EE2-9846-3AB0B24A35D3Q47657420-CBB49D9B-5751-4BB4-A97F-57F4AA645AA0Q47919692-EE36E78E-6D7C-4A1A-96E9-6B46271D7497Q48098788-65ABCD1D-1FB7-44C7-96D6-87373F1133D8Q49616067-1414FA4F-0B96-45BD-A40D-95DD2DBFE17CQ51746631-D73ACB3A-4288-4C1B-BBC8-93C026E78263Q53583024-17F1F8D6-7984-49AA-95EF-C8CA9BB31404Q53586149-9048E993-554C-433B-9FF0-4E428ACA163EQ53837944-F378C2E3-EE67-483C-AE36-EE8A6926A3C7Q55163806-A84AC128-9BBD-4052-8D74-DA1025721B39Q55286574-FA979EF4-6231-4C03-8607-83DB5EF94922Q55334448-79DB13E1-AA5B-4EF8-A9CE-A022D60DF2C9
P2860
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@en
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@nl
type
label
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@en
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@nl
prefLabel
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@en
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@nl
P2093
P2860
P356
P1476
Lesinurad Combined With Allopu ...... llopurinol (a US-Based Study).
@en
P2093
Chris Storgard
David Fitz-Patrick
Jeff Kopicko
Kenneth G Saag
Maple Fung
Michael A Becker
Nihar Bhakta
Scott Adler
Scott Baumgartner
P2860
P304
P356
10.1002/ART.39840
P577
2016-08-26T00:00:00Z